Published November 17, 2026
| Version v1
Journal article
Open
Inhibition of the mammalian target of rapamycin (mTOR) as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies - A review of the evidence
Description
mTOR inhibition shows antiepileptogenic effects in tuberous sclerosis mouse models and limited clinical data; evidence remains preclinical and not definitive.